Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Alvarez

Showing results (411-420 of 440) with videos related to

Pageof 44
Sort By:
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Infection Control and Hospital Epidemiology|April 20, 2006
Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control ConsortiumCarlos Alvarez Moreno, Victor D Rosenthal, Narda Olarte, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 19, 2014
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II allelesBelén de la Hera, Elena Urcelay, David Brassat, et al.
Health Policy and Planning|November 18, 2024
Thinking politically about intersectoral action: Ideas, Interests and Institutions shaping political dimensions of governing during COVID-19Fran Baum, Connie Musolino, Toby Freeman, et al.
Gaceta Sanitaria|March 6, 2019
[Gaceta Sanitaria in 2018. Strengthening the presence in Latin America and promoting the publication of essential issues for the National Health System]Clara Bermúdez-Tamayo, Miguel Negrín Hernández, Juan Alguacil, et al.
Gaceta Sanitaria|March 7, 2018
[Gaceta Sanitaria in 2017. Improving the quality of our journal]Clara Bermúdez-Tamayo, Miguel Negrín Hernández, Juan Alguacil, et al.
Expert Review of Vaccines|August 15, 2022
Further implications on the global real-world vaccine effectiveness against SARS-CoV-2Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 8, 2025
Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD studyOvidio Fernández, Aurea Molina, Urbano Anido-Herranz, et al.
Lancet (London, England)|August 11, 2020
The need for an independent evaluation of the COVID-19 response in SpainAlberto García-Basteiro, Carlos Alvarez-Dardet, Alex Arenas, et al.
Journal of Infection in Developing Countries|February 22, 2022
Evaluation of respiratory anatomical-functional sequelae in patients who recovered from COVID-19Margarita de la Luz Martinez-Fierro, Jose Isaias Badillo-Almaraz, Jose Ramon Muñoz-Torres, et al.
Pageof 44

Showing results (411-420 of 440) with videos related to

Sort By:
Pageof 44
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Infection Control and Hospital Epidemiology|April 20, 2006
Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control ConsortiumCarlos Alvarez Moreno, Victor D Rosenthal, Narda Olarte, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 19, 2014
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II allelesBelén de la Hera, Elena Urcelay, David Brassat, et al.
Health Policy and Planning|November 18, 2024
Thinking politically about intersectoral action: Ideas, Interests and Institutions shaping political dimensions of governing during COVID-19Fran Baum, Connie Musolino, Toby Freeman, et al.
Gaceta Sanitaria|March 6, 2019
[Gaceta Sanitaria in 2018. Strengthening the presence in Latin America and promoting the publication of essential issues for the National Health System]Clara Bermúdez-Tamayo, Miguel Negrín Hernández, Juan Alguacil, et al.
Gaceta Sanitaria|March 7, 2018
[Gaceta Sanitaria in 2017. Improving the quality of our journal]Clara Bermúdez-Tamayo, Miguel Negrín Hernández, Juan Alguacil, et al.
Expert Review of Vaccines|August 15, 2022
Further implications on the global real-world vaccine effectiveness against SARS-CoV-2Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 8, 2025
Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD studyOvidio Fernández, Aurea Molina, Urbano Anido-Herranz, et al.
Lancet (London, England)|August 11, 2020
The need for an independent evaluation of the COVID-19 response in SpainAlberto García-Basteiro, Carlos Alvarez-Dardet, Alex Arenas, et al.
Journal of Infection in Developing Countries|February 22, 2022
Evaluation of respiratory anatomical-functional sequelae in patients who recovered from COVID-19Margarita de la Luz Martinez-Fierro, Jose Isaias Badillo-Almaraz, Jose Ramon Muñoz-Torres, et al.
Pageof 44